BioMarin Expands Again in Enzyme Replacement, Paying $70M for Long-Acting Fabry Drug
BioMarin positive factors rights to a Fabry illness enzyme substitute remedy with potential dosing benefits over merchandise from Sanofi and ...
Tag: BioMarin
BioMarin to buy rare disease focused Amicus for $4.8B
BioMarin said Friday it would purchase Amicus Therapeutics for $4.8 billion, merging two rare disease-focused biotechs founded around the turn ...
Discover the latest in health and fitness with Your Health 247. Get expert advice, workout routines, healthy recipes, and mental wellness tips to lead a healthier, happier life. Stay informed and empowered with us!